Preparation method of quality control serum for quality control of centrifugal microfluidic chips

A microfluidic chip and centrifugal technology, applied in the field of medical testing, can solve the problems of insufficient automatic biochemical testing instruments and facilities, lack of testing professionals, etc., and achieve the effects of avoiding matrix effects, sufficient sources, and easy access.

Active Publication Date: 2018-06-12
NINGBO MEIKANG BAOSHENG BIOMEDICAL ENG
View PDF6 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, hospitals above the middle level have good software and hardware facilities, but basic medical institutions, especially health center

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of quality control serum for quality control of centrifugal microfluidic chips
  • Preparation method of quality control serum for quality control of centrifugal microfluidic chips
  • Preparation method of quality control serum for quality control of centrifugal microfluidic chips

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] 1. Add 0.6% (mass percent) cholesterol sodium sulfate to bovine plasma, heat to 65°C, and cool to room temperature after completely dissolving;

[0027] 2. Add 0.02% (mass percentage) potassium dihydrogen phosphate to the solution obtained in step 1;

[0028] 3. Add 0.04% (mass percent) ammonium ferric sulfate dodecahydrate successively in distilled water, 0.5% (mass percent) calcium chloride, 0.2% (mass percent) magnesium sulfate heptahydrate, 0.6% (mass percent) urea (urea), 9% (mass percentage) of sodium chloride, 0.01% (mass percentage) of zinc sulfate heptahydrate, 0.01% (mass percentage) of copper sulfate pentahydrate, 0.06% (mass percentage) of glycine Cholic acid, 2% (mass percentage) of glucose, 0.03% (mass percentage) of creatinine, 0.08% (mass percentage) of uric acid, 0.07% (mass percentage) of glyceryl triolein, the dissolution of the previous material is completed and mixed uniformly Then add the next substance;

[0029] 4. Mix the solutions obtained in ...

Embodiment 2

[0033] 1. Add 1.0% (mass percent) cholesterol sodium sulfate to bovine plasma, heat to 65°C, and cool to room temperature after completely dissolving;

[0034] 2. Add 0.06% (mass percentage) potassium dihydrogen phosphate to the solution obtained in step 1;

[0035]3. Add 0.08% (mass percent) ammonium ferric sulfate dodecahydrate successively in distilled water, 0.9% (mass percent) calcium chloride, 0.6% (mass percent) magnesium sulfate heptahydrate, 1% (mass percent) urea, 13% (mass percentage) of sodium chloride, 0.03% (mass percentage) of zinc sulfate heptahydrate, 0.03% (mass percentage) of copper sulfate pentahydrate, 0.2% (mass percentage) of glycocholic acid, 4% (mass percentage) of glucose, 0.06% (mass percentage) of creatinine, 0.2% (mass percentage) of uric acid, 0.11% (mass percentage) of glyceryl trioleate, the last material is dissolved and then added after mixing evenly the next substance;

[0036] 4. Mix the solutions obtained in step 2 and step 3 uniformly ac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of quality control serum for quality control of centrifugal microfluidic chips. The method comprises the following steps: adding 0.6 to 1.0 percent of cholesteryl sodium sulfate into bovine plasma, and adding 0.02 to 0.06 percent of monopotassium phosphate; sequentially adding 0.04 to 0. 08 percent of ammonium ferric sulfate dodecahydrate, 0.5 to 0.9 percent of calcium chloride, 0.2 to 0.6 percent of bitter salt, 0.6 to 1 percent of urea, 9 to 13 percent of sodium chloride, 0.01 to 0.03 percent of zinc vitriol, 0.01 to 0.03 percent of chalcanthite,0.06 to 0.2 percent of glycocholic acid, 2 to 4 percent of glucose, 0.03 to 0.06 percent of creatinine, 0.08 to 0.2 percent of uric acid, and 0.07 to 0.11 percent of triolein into water; uniformly mixing obtained solution; adding glycol, saccharose and triton X-100, and uniformly mixing; sequentially adding albumin bovine serum, sodium azide, alanine aminotransferase, aspartic transaminase, alkaline phosphatase, lipase and creatine kinase, uniformly mixing, and performing freeze drying. The method has the advantages that the source of the raw materials is sufficient, the raw materials are easyto get, possible matrix effect is furthest avoided, and precipitation of the raw materials is prevented.

Description

technical field [0001] The invention belongs to the technical field of medical testing, and in particular relates to a method for preparing a plasma quality control product used for quality control of a centrifugal microfluidic chip. Background technique [0002] Medical examination is an important part of clinical medicine. The test results are important data support for clinicians in the work of patient disease diagnosis, treatment monitoring, and prognosis judgment, and are an indispensable means in modern medicine. In my country, with the rapid development of the national economy, the continuous progress of the society, the increase of the total population and the improvement of the quality of the population, the public pays more and more attention to their own health. higher requirement. In the field of medical testing, with the continuous introduction of new technologies, new concepts and new thinking, there are two major development trends in medical testing technolog...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N35/00G01N33/96
CPCG01N33/96G01N35/00623
Inventor 邹炳德邹继华徐秀芬沃燕波臧海燕
Owner NINGBO MEIKANG BAOSHENG BIOMEDICAL ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products